Bridging the gaps in cancer care for Hispanics: Striving for equity and fairness in scientific advancements

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Our Hispanic community is a vibrant and essential part of the American tapestry, contributing richly to the country’s society, culture, and economy. Yet, when it comes to healthcare, this community grapples with significant disparities, especially in cancer care. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Mecker G. Möller, MD
Surgical oncologist, Professor of surgery, University of Chicago Medicine Comprehensive Cancer Center
Table of Contents

YOU MAY BE INTERESTED IN

First-line treatment with the triplet combination of encorafenib, cetuximab, and mFOLFOX6 significantly improved survival compared to the standard of care in patients with BRAF V600E-mutated metastatic colorectal cancer, according to new data from the phase III BREAKWATER trial led by researchers from the University of Texas MD Anderson Cancer Center.
Mecker G. Möller, MD
Surgical oncologist, Professor of surgery, University of Chicago Medicine Comprehensive Cancer Center

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login